Determinants of antiretroviral therapy adherence in northern Tanzania: A comprehensive picture from the patient perspective

BMC Public Health

Volumn 12, Issue 1, 2012, Pages

  Lyimo, Ramsey A ^a   De Bruin, Marijn ^b   Van Den Boogaard, Jossy ^c   Hospers, Harm J ^d   Van Der Ven, André ^c   Mushi, Declare ^e  

^a KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MALE; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; SOCIAL SUPPORT; STATISTICS; TANZANIA;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATION; SOCIAL SUPPORT; TANZANIA; YOUNG ADULT;

EID: 84865480361     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-12-716     Document Type: Review

References (34)

1. AIDS Epidemic update. UNAIDS, Geneva: UNAIDS 2009
2. UNGASS/TACAIDS, UNGASS Reporting for 2010: Tanzania Mainland and Zanzibar 2010
3. Antiretreoviral adherence, viral fitness and HIV disease progression: a tangled web is woven. Lucas GM, J AntimicrobChemother 2005 55 413 416 (Pubitemid 40542576)
4. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Mannheimer S, Friedland G, Matts J, Child C, Chesney M, Clin Infect Dis 2002 34 8 1115 1121 10.1086/339074 11915001 (Pubitemid 34289685)
5. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, et al. JAMA 2006 296 6 679 690 10.1001/jama.296.6.679 16896111 (Pubitemid 44200639)
6. Forming Attitudes that Predict Future Behavior: A Meta-Analysis of the Attitude-Behavior Relation. Glasman LR, Albarracin D, Psychol Bull 2006 132 5 778 822 16910754 (Pubitemid 44306758)
7. The theory of planned behavior. Ajzen I, Organ Behav Hum Decis Process 1991 50 179 211 10.1016/0749-5978(91)90020-T
8. Perceived Behavioral Control, Self-Efficacy, Locus of Control, and the Theory of Planned Behavior. Ajzen I, J Appl Soc Psychol 2002 32 665 683 10.1111/j.1559-1816.2002.tb00236.x
9. Theory- and evidence-based intervention to improve adherence to antiretroviral therapy among HIV-infected patients in the Netherlands: a pilot study. de Bruin M, Hospers HJ, van den Borne HW, Kok G, Prins JM, AIDS Patient Care STDS 2005 19 6 384 394 10.1089/apc.2005.19.384 15989434 (Pubitemid 40962013)
10. Self-Regulatory Processes Mediate the Intention-Behavior Relation for Adherence and Exercise Behaviors. de Bruin M, Sheeran P, Kok G, Hiemstra A, Prins JM, Hospers HJ, van Breukelen GJ, Health Psychol 2012
11. Standard care impacts intervention effects in HAART adherence RCTs: A meta-analysis. de Bruin M, Viechtbauer W, Schaalma HP, Kok G, Abraham C, Hospers HJ, Arch Intern Med 2010 170 3 240 250 10.1001/archinternmed.2009.536 20142568
12. Standard care quality determines treatment outcomes in control groups of HAART-adherence intervention studies: implications for the interpretation and comparison of intervention effects. de Bruin MVW, Hospers HJ, Schaalma HP, Kok G, Health Psycho 2009 28 6 668 674
13. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Raph LH, Carole L, Wallis, Cissy, Kityo, Margaret, Siwale, Kishor, Mandaliya, Lancet Infect Dis 2012 12 8 585 586 10.1016/S1473-3099(12)70173-1 22835893
14. Using framework-based synthesis for conducting reviews of qualitative studies. Dixon-Woods M, BMC Med 2011 9 39 9 39 21269451
15. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE, Clin Infect Dis 2003 37 8 1112 1118 10.1086/378301 14523777 (Pubitemid 37323668)
16. Social Cognitive Theory: an agentic perspective. Bandura A, Annu Rev Psychol 2001 52 1 26 10.1146/annurev.psych.52.1.1 11148297 (Pubitemid 33705565)
17. Sero-positive African American's beliefs about alcohol and their impact on anti-retroviral adherence. Sankar AWT, Neufeld S, Luborsky M, AIDS Behav 2007 11 2 195 203 10.1007/s10461-006-9144-0 16799842
18. Identifying barriers to treatment adherence and related attitudinal patterns in adolescents with cystic fibrosis. Dziuban EJ, Saab-Abazeed L, Chaudhry SR, Streetman DS, Nasr SZ, Pediatr Pulmonol 2010 45 5 450 458 10.1002/ppul.21195 20425852
19. Ullrich G, Lapses in adherence: explaining patients reasons Bad Hofgastein, Austria 2010
20. Helman CG, Culture, Health and Illness HodderAmold, London 5 2007
21. Motivational Interviewing and Self-Determination Theory. Markland D, Ryan RM, Tobin VJ, Rollnick S, Journal of Social and Clin Psyc 2005 24 6 811 831 10.1521/jscp.2005.24.6.811 (Pubitemid 41657552)
22. Baseline predictors of ninety percent or higher antiretroviral therapy adherence in a diverse urban sample: the role of patient autonomy and fatalistic religious beliefs. Finocchario-Kessler S, Catley D, Berkley-Patton J, Gerkovich M, Williams K, Banderas J, Goggin K, AIDS Patient Care STDS 2011 25 2 103 111 10.1089/apc.2010.0319 21235403
23. The link between religion and HAART adherence in pediatric HIV patients. Park J, Nachman S, AIDS Care 2010 22 5 556 561 10.1080/09540120903254013 20397076
24. Missed opportunities for religious organizations to support people living with HIV/AIDS: findings from Tanzania. Watt MH, Maman S, Jacobson M, Laiser J, John M, AIDS Patient Care STDS 2009 23 5 389 394 10.1089/apc.2008.0195 19335171
25. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Zachariah R, Teck R, Buhendwa L, Fitzerland M, Labana S, Chinji C, Humblet P, Harries AD, Trans R Soc Trop Med Hyg 2007 101 1 79 84 10.1016/j.trstmh.2006.05.010 16962622 (Pubitemid 44760916)
26. Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Event Monitoring System. Lyimo RA, van den Boogaard J, Msoka E, Hospers HJ, van der Ven A, Mushi D, de Bruin M, BMC Publ Health 2011 11 92 10.1186/1471-2458-11-92
27. UNAIDS, Handbook on access to HIV/AIDS related- treatment Geneva 2003
28. Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. Spacek LA, Shihab HM, Kamya MR, Mwesigire D, Ronald A, Mayanja H, Moore RD, Bates M, Quinn TC, Clin Infect Dis 2006 42 2 252 259 10.1086/499044 16355337 (Pubitemid 43054199)
29. HIV interventions to reduce HIV/AIDS stigma: a systematic review. Sengupta S, Banks B, Jonas D, Miles MS, Smith GC, AIDS Behav 2011 15 6 1075 1087 10.1007/s10461-010-9847-0 21088989
30. Relationship of depression and catastrophizing to pain, disability, and medication adherence in patients with HIV-associated sensory neuropathy. Lucey BP, Clifford DB, Creighton J, Edwards RR, McArthur JC, Haythornthwaite J, AIDS Care 2011 23 8 921 928 10.1080/09540121.2010.543883 21500021
31. Clinical experience with nevirapine combined with tenofovir plus emtricitabine or lamivudine-containing regimens in HIV-infected subjects. Smith DE, Chan DJ, Maruszak H, Jeganathan S, Int J STD AIDS 2011 22 4 228 230 10.1258/ijsa.2010.010258 21515757
32. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients. Monforte A, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, Angarano G, Colangeli V, De Luca A, Ippolito G, et al. AIDS 2000 14 5 499 507 10.1097/00002030-200003310-00005 10780712 (Pubitemid 30209692)
33. WHO, Scaling up antiretroviral treatment in resource limited settings: treatment guidelines for public health approach Geneva 2004
34. Bartholomew LK, Parcel GS, Kok G, Gottlieb NH, Fernández ME, Planning health promotion programs; an Intervention Mapping approach San Francisco CA: Jossey-Bass 3 2011 23032121